Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05596591 · ClinicalTrials.gov registry record · NA

Focused Extracorporeal Shockwave Therapy for Knee Arthritis

A NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Kessler Foundation.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
2
Study locations

NCT05596591 is a NA study of Knee Osteoarthritis and Knee Pain Chronic that is actively recruiting participants, run by Kessler Foundation. The registered enrollment target is 15 participants, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05596591, a NA study of Knee Osteoarthritis and Knee Pain Chronic, is actively recruiting participants, sponsored by Kessler Foundation.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
2
Study locations

Study Summary

Subchondral bone marrow lesions (BMLs) in knee osteoarthritis (OA) are strongly associated with presence and severity of knee pain, structural deterioration, disease progression with an increased risk of total knee arthroplasty. OA-related BMLs may regress or resolve within 30 months which could be associated with long lasting disability. It has been reported that BMLs persist in the majority of knee OA patients. Different treatment strategies have been proposed including rest and protected weight-bearing, bisphosphonates, subchondroplasty and intraosseous orthobiologic injection. However, conservative treatment response takes a long time and other interventions may be considered invasive procedures that show varying results with several side effects. Focused extracorporeal shockwave therapy (f-ESWT) has been established as a safe non-invasive treatment with positive results in different bone disorders that share the same pathological features of BMLs. This is an exploratory, randomized-controlled, pilot study to determine the efficacy and safety of f-ESWT compared to the standard-of-care (analgesics and protected weight bearing) for the treatment of BMLs in patients with knee OA. Thirty subjects with knee OA who have history of knee pain at rest and during walking with the confirmed diagnosis of subchondral BML(s) on magnetic resonance imaging (MRI) despite at least 4 weeks of conservative treatment will be enrolled into this study. Subjects will receive a total of 4 sessions (at high energy level) over 4 consecutive weeks. Participants will be evaluated for adverse events and changes in pain intensity and knee function, using an 11-point numerical rating scale (NRS; 0-10, with anchors "no pain" and "pain as bad as you can imagine") and; the Knee injury and Osteoarthritis Outcome Score, respectively. Subjects will be assessed with these outcome measures at baseline, 1 month, 2 months, 3 months, and 6 months after the treatment. MRI of the involved knee will be perf

Interventions

  • DEVICE Focused extracorporeal shockwave therapy

Study Locations (2)

New Jersey

  • New Jersey Regenerative Institute - Cedar Knolls
  • Nathan Hogaboom - West Orange

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-10-13
Est. Completion 2026-12
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT05596591

The ClinicalTrials.gov registry entry for NCT05596591 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Focused extracorporeal shockwave therapy is the first listed.

NCT05596591 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05596591 about?

NCT05596591 is a clinical study titled "Focused Extracorporeal Shockwave Therapy for Knee Arthritis". Subchondral bone marrow lesions (BMLs) in knee osteoarthritis (OA) are strongly associated with presence and severity of knee pain, structural deterioration, disease progression with an increased risk of total knee arthroplasty. OA-related BMLs may regress or resolve within 30 months which could be ...

What is the current status of trial NCT05596591?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-10-13. Estimated completion is 2026-12.

What conditions does trial NCT05596591 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Pain Chronic, Bone Marrow Edema.

What interventions are being tested in trial NCT05596591?

The interventions under investigation include: Focused extracorporeal shockwave therapy (DEVICE).

Who is sponsoring clinical trial NCT05596591?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05596591 being conducted?

This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.